Advertisement
As global leaders in tobacco control commemorate World No Tobacco Day(WNTD) on May 31st, the rallying cry is to prevent young people from startingto smoke. While the 2008 theme, "Tobacco-Free Youth" calls for additionallimitations on the marketing practices of cigarette marketers and othercomprehensive changes, a major determining factor of children's tobacco use isthe smoking status of their parents.
Advertisement
"By quitting smoking, parents can play a major role in helping to end thevicious cycle of passing addiction from generation to generation," said HowardMarsh, M.D., medical director, GlaxoSmithKline Consumer Healthcare. "Parentswho want to take this important step on May 31st should get help from provensmoking cessation treatments such as therapeutic nicotine to increase theirchances of staying off cigarettes for good."
Smoking remains one of the leading causes of preventable death and diseaseand one of the most powerful and important addictions to break. That said,many smokers can't do it alone. Evidence-based treatments such as therapeuticnicotine including (US: NicoDerm(R) CQ(R), Nicorette and Commit) (ex-US)NiQuitin(R) and Nicabate(R) in combination with counseling offers asignificantly better chance of quitting versus cold turkey.(3)
GlaxoSmithKline's line of therapeutic nicotine products such as Nicorettegum (United States only), NicoDerm CQ patch and Commit lozenge, and NiQuitinand Nicabate brands outside of the United States, are easy to access inthousands of retail outlets and pharmacies worldwide. These products aredesigned specifically to break the daily addiction cycle by offering agradual, controlled delivery of nicotine to the body, helping to relievecravings and withdrawal symptoms.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largestover-the-counter consumer healthcare products companies. Its more than 30well-known brands include the leading smoking cessation products,Nicorette(R), NicoDerm(R) and Commit(R), NiQuitin and Nicabate, as well asmany medicine cabinet staples such as Abreva(R), Aquafresh(R), Sensodyne(R)and Tums(R). GlaxoSmithKline Consumer Healthcare continues to developinnovative products to help all smokers find their best support system andachieve their goal of being cigarette free.
About GlaxoSmithKline
GlaxoSmithKline is one of the world's leading research-basedpharmaceutical and consumer healthcare companies. GlaxoSmithKline iscommitted to improving the quality of human life by enabling people to domore, feel better and live longer.
NOTE: GlaxoSmithKline distributes Nicorette(R) gum, Nicoderm(R) patch andCommit(R) lozenge the United States. Outside of the U.S., its smokingcessation patch and lozenge are marketed as Nicabate(R) in Australia andNiQuitin(R) in other countries.Consider these statistics: -- Therapeutic nicotine smoking cessation aids, Nicorette(R) gum (United States only), NicoDerm CQ patch and Commit(R) lozenge, and NiQuitin and Nicabate brands outside of the United States, have helped over 6.5 million people around the world quit smoking and, as a result, have significantly reduced their exposure to the risks of cancer and other smoking-related diseases.(4) -- More than one billion patches, lozenges and gums were sold in 2007 to help smokers quit.(5) -- Quitters using therapeutic nicotine can double their chances of success versus quitting without he
